1088 related articles for article (PubMed ID: 26588861)
1. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
[TBL] [Abstract][Full Text] [Related]
2. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome.
Liu W; Guo W; Wu J; Luo Q; Tao F; Gu Y; Shen Y; Li J; Tan R; Xu Q; Sun Y
Biochem Pharmacol; 2013 May; 85(10):1504-12. PubMed ID: 23506741
[TBL] [Abstract][Full Text] [Related]
3. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation.
Sun Y; Zhao Y; Yao J; Zhao L; Wu Z; Wang Y; Pan D; Miao H; Guo Q; Lu N
Biochem Pharmacol; 2015 Mar; 94(2):142-54. PubMed ID: 25677765
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation.
Liu X; Zhou W; Zhang X; Lu P; Du Q; Tao L; Ding Y; Wang Y; Hu R
Biochem Pharmacol; 2016 Jul; 112():37-49. PubMed ID: 27184504
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome.
Qin M; Long F; Wu W; Yang D; Huang M; Xiao C; Chen X; Liu X; Zhu YZ
Free Radic Biol Med; 2019 Jun; 137():99-109. PubMed ID: 31026586
[TBL] [Abstract][Full Text] [Related]
6. Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflammasome activation.
Guo W; Liu W; Jin B; Geng J; Li J; Ding H; Wu X; Xu Q; Sun Y; Gao J
Int Immunopharmacol; 2015 Feb; 24(2):232-238. PubMed ID: 25523461
[TBL] [Abstract][Full Text] [Related]
7. Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway.
Wang K; Lv Q; Miao YM; Qiao SM; Dai Y; Wei ZF
Biochem Pharmacol; 2018 Sep; 155():494-509. PubMed ID: 30071202
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming.
Liu X; Zhang X; Ding Y; Zhou W; Tao L; Lu P; Wang Y; Hu R
Antioxid Redox Signal; 2017 Jan; 26(1):28-43. PubMed ID: 27308893
[TBL] [Abstract][Full Text] [Related]
9. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.
Bauer C; Duewell P; Mayer C; Lehr HA; Fitzgerald KA; Dauer M; Tschopp J; Endres S; Latz E; Schnurr M
Gut; 2010 Sep; 59(9):1192-9. PubMed ID: 20442201
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.
Simovic Markovic B; Nikolic A; Gazdic M; Bojic S; Vucicevic L; Kosic M; Mitrovic S; Milosavljevic M; Besra G; Trajkovic V; Arsenijevic N; Lukic ML; Volarevic V
J Crohns Colitis; 2016 May; 10(5):593-606. PubMed ID: 26786981
[TBL] [Abstract][Full Text] [Related]
11. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway.
Liu Q; Zuo R; Wang K; Nong FF; Fu YJ; Huang SW; Pan ZF; Zhang Y; Luo X; Deng XL; Zhang XX; Zhou L; Chen Y
Acta Pharmacol Sin; 2020 Jun; 41(6):771-781. PubMed ID: 31937929
[TBL] [Abstract][Full Text] [Related]
12. PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway.
Mei Y; Fang C; Ding S; Liu X; Hu J; Xu J; Mei Q
Int Immunopharmacol; 2019 Oct; 75():105776. PubMed ID: 31351364
[TBL] [Abstract][Full Text] [Related]
13. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
[TBL] [Abstract][Full Text] [Related]
14. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.
Gong Z; Zhao S; Zhou J; Yan J; Wang L; Du X; Li H; Chen Y; Cai W; Wu J
Mol Immunol; 2018 Dec; 104():11-19. PubMed ID: 30396035
[TBL] [Abstract][Full Text] [Related]
15. Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation.
Ka SM; Lin JC; Lin TJ; Liu FC; Chao LK; Ho CL; Yeh LT; Sytwu HK; Hua KF; Chen A
Arthritis Res Ther; 2015 Nov; 17():331. PubMed ID: 26584539
[TBL] [Abstract][Full Text] [Related]
16. A new pharmacological effect of levornidazole: Inhibition of NLRP3 inflammasome activation.
Wang X; Wang S; Hu C; Chen W; Shen Y; Wu X; Sun Y; Xu Q
Biochem Pharmacol; 2015 Sep; 97(2):178-88. PubMed ID: 26212544
[TBL] [Abstract][Full Text] [Related]
17. Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors.
Bauer C; Duewell P; Lehr HA; Endres S; Schnurr M
Dig Dis; 2012; 30 Suppl 1():82-90. PubMed ID: 23075874
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
[TBL] [Abstract][Full Text] [Related]
19. Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition.
Guo W; Hu S; Elgehama A; Shao F; Ren R; Liu W; Zhang W; Wang X; Tan R; Xu Q; Sun Y; Jiao R
J Pharmacol Sci; 2015 Oct; 129(2):101-6. PubMed ID: 26320672
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
